Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Balance Sheets

v3.19.3
Condensed Interim Balance Sheets - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 10,320,183 $ 11,471,243
Amounts receivable 55,208 143,225
Deposits 8,864,346 8,541,630
Prepaid expense 635,212 586,581
Total Current Assets 19,874,949 20,742,679
Patent Rights 1,337,975 1,172,485
Total Assets 21,212,924 21,915,164
Current Liabilities:    
Accounts payable and accrued liabilities 12,231,777 6,447,888
Warrant liability 27,307,700 11,250,167
Total Liabilities 39,539,477 17,698,055
Shareholders' Equity (Deficiency)    
Share Capital 189,723,070 170,502,394
Contributed Surplus 7,643,817 6,652,409
Deficit (215,693,440) (172,937,694)
Total Equity / (Deficiency) (18,326,553) 4,217,109
Total Liabilities and Equity / (Deficiency) $ 21,212,924 $ 21,915,164